Journal of the American Academy of Dermatology
Volume 61, Issue 1 , Pages 104-111 , July 2009

Lichen planus–like eruptions: An emerging side effect of tumor necrosis factor-α antagonists

  • Adam Asarch, BA

      Affiliations

    • Department of Dermatology, Tufts Medical Center, Boston, Massachusetts
    • ,
  • Alice B. Gottlieb, MD, PhD

      Affiliations

    • Department of Dermatology, Tufts Medical Center, Boston, Massachusetts
    • ,
  • Jin Lee, MD, MBA

      Affiliations

    • Department of Dermatology, Tufts Medical Center, Boston, Massachusetts
    • ,
  • Katherine S. Masterpol, MD

      Affiliations

    • Department of Dermatology, Tufts Medical Center, Boston, Massachusetts
    • ,
  • Pamela L. Scheinman, MD

      Affiliations

    • Department of Dermatology, Tufts Medical Center, Boston, Massachusetts
    • ,
  • Miguel J. Stadecker, MD, PhD

      Affiliations

    • Department of Pathology, Tufts Medical Center, Boston, Massachusetts
    • ,
  • Elena M. Massarotti, MD

      Affiliations

    • Department of Rheumatology, Brigham and Women's Hospital, Boston, Massachusetts
    • ,
  • Michelle L. Bush, MD

      Affiliations

    • Department of Dermatology, Tufts Medical Center, Boston, Massachusetts
    • Corresponding Author InformationReprint requests: Michelle L. Bush, MD, Department of Dermatology, Tufts Medical Center, 800 Washington St, 114, Boston, MA 02111.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by a generous grant from Ms Joan Fabry. Tufts Medical Center has received educational/research grants from Centocor, Amgen, Wyeth, Immune Control, Celgene, Incyte, and Abbott.

 Disclosure: Almost all of Dr Gottlieb's income is paid to her employer. Dr Gottlieb has speakers' bureau memberships with Amgen Inc and Wyeth Pharmaceuticals. Dr Gottlieb has current consulting/advisory board agreements with Amgen Inc, Centocor Inc, Wyeth Pharmaceuticals, Celgene Corp, Bristol Myers Squibb Co, Beiersdorf Inc, Warner Chilcott, Abbott Laboratories, Roche, Sankyo, Medarex, Kemia, Celera, TEVA, Actelion, UCB, Novo Nordisk, Almirall, Immune Control, RxClinical, Dermipsor Ltd, Medacorp, DermiPsor, Can-Fite, Incyte, and Corgentech. Ms Fabry is a patient of Dr Gottlieb's and gave an unrestricted grant to support psoriasis research. Dr Massarotti receives consulting/honoraria from Bristol Myers Squibb, UCB, Genentech, Abbott, and PAI. Dr Bush has received research funding from Centocor. Mr Asarch, and Drs Lee, Masterpol, Scheinman, and Stadecker have no conflicts of interest to declare.

 Case 1 was presented at a meeting of the New England Dermatological Society at Tufts Medical Center, Boston, MA, on December 1, 2007.

PII: S0190-9622(08)01212-7

doi: 10.1016/j.jaad.2008.09.032

Journal of the American Academy of Dermatology
Volume 61, Issue 1 , Pages 104-111 , July 2009

Article Tools

* Image Usage & Resolution